BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tiscia GL, Ostuni A, Cascavilla N, Cappucci F, Scalzulli P, Battista C, Abrescia A, Aucella F, Buquicchio C, Brigante M, D’andrea G, Di Paolo B, Giordano G, Infante B, Piano S, Ranieri P, Tullo L, Grandone E. Validation of PLASMIC score and follow-up data in a cohort of patients with suspected microangiopathies from Southern Italy. J Thromb Thrombolysis 2018;46:174-9. [DOI: 10.1007/s11239-018-1674-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Tiscia G, Sartori MT, Giuffrida G, Ostuni A, Cascavilla N, Nicolosi D, Battista C, Santeramo TM, Melillo L, Giordano G, Cappucci F, Fischetti L, Chinni E, Tarantini G, Cerbo A, Bertomoro A, Fabris F, Grandone E. Focus on Key Issues in Immune Thrombotic Thrombocytopenic Purpura: Italian Experience of Six Centers. J Clin Med 2021;10:5702. [PMID: 34884404 DOI: 10.3390/jcm10235702] [Reference Citation Analysis]
2 Paydary K, Banwell E, Tong J, Chen Y, Cuker A. Diagnostic accuracy of the PLASMIC score in patients with suspected thrombotic thrombocytopenic purpura: A systematic review and meta-analysis. Transfusion 2020;60:2047-57. [PMID: 32757237 DOI: 10.1111/trf.15954] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Moosavi H, Ma Y, Miller MJ, Duncan A. Validation of PLASMIC score: an academic medical center case series (2012-present). Transfusion 2020;60:1536-43. [PMID: 32588918 DOI: 10.1111/trf.15916] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 D'Andrea G, Margaglione M. Rare Defects: Looking at the Dark Face of the Thrombosis. Int J Environ Res Public Health 2021;18:9146. [PMID: 34501736 DOI: 10.3390/ijerph18179146] [Reference Citation Analysis]
5 Tiscia G, Favuzzi G, De Laurenzo A, Cappucci F, Fischetti L, Colaizzo D, Chinni E, Florio L, Miscio G, Piscitelli AP, Mastroianno M, Grandone E. The Prognostic Value of ADAMTS-13 and von Willebrand Factor in COVID-19 Patients: Prospective Evaluation by Care Setting. Diagnostics (Basel) 2021;11:1648. [PMID: 34573989 DOI: 10.3390/diagnostics11091648] [Reference Citation Analysis]
6 Reeves HM, Maitta RW. Comparison of absolute immature platelet count to the PLASMIC score at presentation in predicting ADAMTS13 deficiency in suspected thrombotic thrombocytopenic purpura. Thrombosis Research 2022. [DOI: 10.1016/j.thromres.2022.05.008] [Reference Citation Analysis]
7 Baysal M, Ümit E, Kırkızlar HO, Demir AM. Comparison of Clinical Scoring Systems in the Management of Patients with Microangiopathic Hemolytic Anemia and Thrombocytopenia. Turk J Haematol 2021;38:64-8. [PMID: 33161686 DOI: 10.4274/tjh.galenos.2020.2020.0348] [Reference Citation Analysis]
8 Tiscia GL, Grandone E. PLASMIC score: Not intended to replace but rather to prompt the ADAMTS13 testing. Transfusion 2020;60:3070-2. [PMID: 33285003 DOI: 10.1111/trf.16105] [Reference Citation Analysis]
9 Gavriilaki E, Koravou E, Chatziconstantinou T, Kalpadaki C, Printza N, Ximeri M, Christoforidou A, Karavalakis G, Kaliou M, Kalaitzidou V, Tassi I, Tzellou M, Touloumenidou T, Papalexandri A, Papathanasiou M, Syrigou A, Kioumi A, Liga M, Kaiafa G, Spyridonidis A, Kapsali E, Kollios K, Mandala E, Vlachaki E, Tsirigotis P, Papadaki E, Lalayanni C, Sakellari I, Anagnostopoulos A. Real-world data of thrombotic microangiopathy management: The key role of ADAMTS13 activity and complement testing. Thrombosis Update 2021;3:100043. [DOI: 10.1016/j.tru.2021.100043] [Reference Citation Analysis]
10 Ostuni A, Tiscia G, Battista C, Favuzzi G, Montinaro V, Pronzo V, Cappucci F, Fischetti L, Gesualdo L, Grandone E. Effective and safe off-label use of caplacizumab treatment in a middle-aged obese male. Transfus Clin Biol 2021;28:89-91. [PMID: 33285299 DOI: 10.1016/j.tracli.2020.11.003] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Gupta GK, Hendrickson JE, Tormey CA. Application of PLASMIC score in prediction of ADAMTS13 deficiency in a pediatric case of acquired thrombotic thrombocytopenic purpura. J Clin Apher 2020;35:140-1. [PMID: 31951292 DOI: 10.1002/jca.21767] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Lee C, Huang Y, Li S, Hsu Y, Chen Y, Chen T. Application of PLASMIC Score in Risk Prediction of Thrombotic Thrombocytopenic Purpura: Real-World Experience From a Tertiary Medical Center in Taiwan. Front Med 2022;9:893273. [DOI: 10.3389/fmed.2022.893273] [Reference Citation Analysis]
13 Grandone E, Vimercati A, Sorrentino F, Colaizzo D, Ostuni A, Ceci O, Capozza M, Tiscia G, De Laurenzo A, Mastroianno M, Cappucci F, Fischetti L, Margaglione M, Cicinelli E, Nappi L. Obstetric outcomes in pregnant COVID-19 women: the imbalance of von Willebrand factor and ADAMTS13 axis. BMC Pregnancy Childbirth 2022;22:142. [PMID: 35189860 DOI: 10.1186/s12884-022-04405-8] [Reference Citation Analysis]
14 Fage N, Orvain C, Henry N, Mellaza C, Beloncle F, Tuffigo M, Geneviève F, Coppo P, Augusto JF, Brilland B. Proteinuria Increases the PLASMIC and French Scores Performance to Predict Thrombotic Thrombocytopenic Purpura in Patients With Thrombotic Microangiopathy Syndrome. Kidney International Reports 2021. [DOI: 10.1016/j.ekir.2021.11.009] [Reference Citation Analysis]
15 Ostuni A, Favuzzi G, Battista C, Tullo A, Cappucci F, Makatsariya A, Tiscia GL, Grandone E. Recurrent thrombocytopenia in pregnancy: is it always an obstetric complication? Intern Emerg Med 2020;15:1271-4. [PMID: 31240581 DOI: 10.1007/s11739-019-02136-x] [Reference Citation Analysis]